Safety and Feasibility of the Application of Thoracic Puncture Tube After Pulmonary Lobectomy
Primary Purpose
Chest Tubes, Pneumonectomy, Minimally Invasive Surgery
Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
thoracic drainage management
Sponsored by

About this trial
This is an interventional treatment trial for Chest Tubes focused on measuring Chest Tubes, Pneumonectomy, Minimally Invasive Surgery
Eligibility Criteria
Inclusion Criteria:
- Age and gender: 18-70 years old, male and female unlimited;
- Cardiopulmonary function can tolerate operation;
- Primary non-small cell lung cancer was diagnosed by preoperative or intraoperative pathology. The surgical ranges are uni-portal VATS lobectomy with or without mediastinal lymph node dissection or sampling. In cases with multiple nodules in other lobes of the same side, small wedge resections are allowed;
- No air leakage was observed intraoperatively. Meanwhile, after operation, there are also no air leakage observed in water seal bottle when patients are changed from lateral decubitus to horizontal position.
- Patients and their family members can understand and are willing to participate in this clinical study and sign the informed consent..
Exclusion Criteria:
- Patients with a severe emphysema or pulmonary bullae;
- Patients with a history of chemotherapy or chemo-radiotherapy;
- Patients with a history of chest surgery;
- Extensive thoracic adhesion ;
- A history of serious mental illness;
- Patients with other conditions considered by the researcher should not participate in the study.
Sites / Locations
- Fujian Medical University Union HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Puncture tube group
Traditional tubes group
Arm Description
After the operation, the traditional traditional silicone tube which placed through the surgical incision was removed in the operating room, and the small puncture tube was retained for thoracic drainage.
Routine thoracic drainage management measures were adopted, that is, both of the small puncture tube and traditional silicone tube were retained after surgery.
Outcomes
Primary Outcome Measures
Incidence of postoperative complications
The incidence of complications within 30 days after surgery in each arm
Secondary Outcome Measures
Incidence of subcutaneous emphysema after operation
The incidence of subcutaneous emphysema after operation in each arm
Incidence of postoperative pneumothorax
The incidence of postoperative pneumothorax in each arm
Full Information
NCT ID
NCT04718272
First Posted
January 18, 2021
Last Updated
May 7, 2021
Sponsor
Fujian Medical University Union Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04718272
Brief Title
Safety and Feasibility of the Application of Thoracic Puncture Tube After Pulmonary Lobectomy
Official Title
Safety and Feasibility of the Application of Thoracic Puncture Tube VS Combination of Puncture Tube and Silicone Tube After Uniportal VATS Pulmonary Lobectomy
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Recruiting
Study Start Date
January 25, 2021 (Actual)
Primary Completion Date
April 30, 2024 (Anticipated)
Study Completion Date
April 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fujian Medical University Union Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
There have been several reports on the feasibility of a no-drain policy after pneumonectomy, but the policy is not widely accepted because silent massive hemorrhage, delayed air leaks, and chylothorax would always be major worries for thoracic surgeons, and all of the researches were retrospective case studies with small sample size and insufficient evidence. Therefore, the purpose of this study is to to evaluate safety and feasibility of an improved policy, the application of a small thoracic puncture tube after pulmonary lobectomy.
Detailed Description
This study will be accepted in patients with uniportal VATS(Video-assisted Thoracoscopic Surgery)lobetomy. A randomized controlled study protocol will be used, and The patients will be devided into two groups: experimental group for the application of a small thoracic puncture tube and control group for the application of Combination of the puncture tube and traditional silicone tube. The intraoperative conditions, postoperative recovery and the incidence of perioperative complications will be compared. The safety and feasibility of the application of the small thoracic puncture tube after pulmonary lobectomy will be evaluated.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chest Tubes, Pneumonectomy, Minimally Invasive Surgery
Keywords
Chest Tubes, Pneumonectomy, Minimally Invasive Surgery
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Puncture tube group
Arm Type
Experimental
Arm Description
After the operation, the traditional traditional silicone tube which placed through the surgical incision was removed in the operating room, and the small puncture tube was retained for thoracic drainage.
Arm Title
Traditional tubes group
Arm Type
No Intervention
Arm Description
Routine thoracic drainage management measures were adopted, that is, both of the small puncture tube and traditional silicone tube were retained after surgery.
Intervention Type
Procedure
Intervention Name(s)
thoracic drainage management
Intervention Description
After uniportal VATS pulmonary lobectomy, the traditional silicone tube which placed through the surgical incision was removed in the operating room in the experimental group.
Primary Outcome Measure Information:
Title
Incidence of postoperative complications
Description
The incidence of complications within 30 days after surgery in each arm
Time Frame
within 30 days after surgery
Secondary Outcome Measure Information:
Title
Incidence of subcutaneous emphysema after operation
Description
The incidence of subcutaneous emphysema after operation in each arm
Time Frame
within 30 days after surgery
Title
Incidence of postoperative pneumothorax
Description
The incidence of postoperative pneumothorax in each arm
Time Frame
within 30 days after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age and gender: 18-70 years old, male and female unlimited;
Cardiopulmonary function can tolerate operation;
Primary non-small cell lung cancer was diagnosed by preoperative or intraoperative pathology. The surgical ranges are uni-portal VATS lobectomy with or without mediastinal lymph node dissection or sampling. In cases with multiple nodules in other lobes of the same side, small wedge resections are allowed;
No air leakage was observed intraoperatively. Meanwhile, after operation, there are also no air leakage observed in water seal bottle when patients are changed from lateral decubitus to horizontal position.
Patients and their family members can understand and are willing to participate in this clinical study and sign the informed consent..
Exclusion Criteria:
Patients with a severe emphysema or pulmonary bullae;
Patients with a history of chemotherapy or chemo-radiotherapy;
Patients with a history of chest surgery;
Extensive thoracic adhesion ;
A history of serious mental illness;
Patients with other conditions considered by the researcher should not participate in the study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Guobing Xu, MD
Phone
15880005394
Email
15880005394@163.com
First Name & Middle Initial & Last Name or Official Title & Degree
Chun Chen, MD
Phone
13365910325
Email
chenchun0209@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chun Chen, MD
Organizational Affiliation
Fujian Medical University Union Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Fujian Medical University Union Hospital
City
Fuzhou
State/Province
Fujian
ZIP/Postal Code
350001
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Guobing Xu, MD
Phone
15880005394
Email
15880005394@163.com
First Name & Middle Initial & Last Name & Degree
Chun Chen, MD
Phone
13365910325
Email
chenchun0209@163.com
12. IPD Sharing Statement
Learn more about this trial
Safety and Feasibility of the Application of Thoracic Puncture Tube After Pulmonary Lobectomy
We'll reach out to this number within 24 hrs